- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02135653
A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer
28. april 2021 oppdatert av: Abramson Cancer Center of the University of Pennsylvania
This study will ascertain the feasibility and effect of Eischens yoga interventions on radiation related fatigue, sexual dysfunction and urinary incontinence in stage I /II prostate cancer patients undergoing radiotherapy with photons and/or protons without prostatectomy.
Subjects must be smoke free and have not taken regular yoga classes 6 months prior to enrollment.
Subjects will participate in twice weekly yoga sessions for 8 weeks and complete 4 quality of life forms 5 times during study.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The feasibility study refers to the ability to recruit patients willing to participate in the Eischens yoga interventional arm.
Those who are recruited during the feasibility study are seemlessly move to the Phase II study, and for this reason the feasibility study and Eischens yoga interventional arms are reported simply as the Eischens yoga interventional arm.
Studietype
Observasjonsmessig
Registrering (Faktiske)
68
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19104
- Abramson Cancer Center of the University of Pennsylvania
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Prøvetakingsmetode
Sannsynlighetsprøve
Studiepopulasjon
Adults with stage I or II prostate cancer undergoing radiation therapy. Enrolled subjects will not have smoked nor taken any regular yoga classes in the 6 months preceding their participation in the study.
Additionally they will have not undergone a surgical prostatectomy
Beskrivelse
Inclusion Criteria:
Patients
- Prostate cancer patients undergoing active radiation therapy (external beam radiation with photons and/ or protons). Prior or concurrent androgen deprivation therapy is permitted.
- Patients of age >18 years, and all races will be included in the study.
- Patients must have an ECOG Performance Score ≤ 1
- All patients must sign an informed consent form
Caregivers
- Subject is age >18 years
- Subject is English-speaking
- Subject must sign an informed consent form
Exclusion Criteria
Patients
- Patients with medical restrictions that may interfere with or prevent them from taking part in the yoga interventions per their physician orders as evaluated by ECOG Performance Status score.
- Active, regular cigarette smokers, such that smoking may interfere with relaxation and breathing modalities of the yoga interventions. (Smokers that have been smoke-free for 6 months may be included)
- Patients who currently practice or have recently practiced yoga (taken a yoga class on a regular basis in the last 6 months).
- Patients who are undergoing chemotherapy for any reason
- Patients with evidence of metastatic disease
Caregivers
- Subjects that are unwilling or unable to provide informed consent
- Subjects with medical restrictions that may interfere with or prevent them from taking part in the yoga interventions
- Active, regular cigarette smokers, such that smoking may interfere with relaxation and breathing modalities of the yoga interventions. (Smokers that have been smoke-free for 6 months may be included)
- Patients who currently practice or have recently practiced yoga (taken a yoga class on a regular basis in the last 6 months).
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
Feasibility Phase: Eischens Yoga Group
|
|
Phase II: Eischens Yoga Group
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Adverse Events
Tidsramme: 8 weeks
|
8 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Brief Fatigue Inventory Score
Tidsramme: 8 weeks
|
A 9 item 11 point Likert-scale that rapidly assesses fatigue severity 0 - 90 range with greater numbers indicating greater levels of fatigue
|
8 weeks
|
Functional Assessment of Cancer Therapy: Physical Well-Being Score
Tidsramme: 8 weeks
|
7 item 5 point Likert-scale questionnaire.
0 - 35 range with larger number implies better physical well-being
|
8 weeks
|
Functional Assessment of Cancer Therapy: Social Well-Being Score
Tidsramme: 8 weeks
|
7 item 5 point Likert-scale questionnaire.
0 - 35 range with larger number implies better social well-being
|
8 weeks
|
Functional Assessment of Cancer Therapy: Emotional Well-Being Score
Tidsramme: 8 weeks
|
6 item 5 point Likert-scale questionnaire.
0 - 30 range with larger number implies better emotional well-being
|
8 weeks
|
Functional Assessment of Cancer Therapy: Functional Well-Being
Tidsramme: 8 weeks
|
7 item 5 point Likert-scale questionnaire.
0 - 35 range with larger number implies better functional well-being
|
8 weeks
|
International Index of Erectile Function Score
Tidsramme: 8 weeks
|
5 item and 5 point Likert-scale The scores range from 0 to 25, with scores >21 indicating normal erectile function and scores <12 indicating moderate to severe ED
|
8 weeks
|
International Prostate Symptom Score
Tidsramme: 8 weeks
|
8 item 6 point Likert-scale Scores on this scale range from 0 to 35, with a score of 8 to 19 indicating moderate urinary symptoms and 20 to 35 severe urinary symptoms
|
8 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: Neha Vapiwala, MD, Abramson Cancer Center of the University of Pennsylvania
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. mars 2013
Primær fullføring (Faktiske)
24. mai 2018
Studiet fullført (Faktiske)
1. desember 2019
Datoer for studieregistrering
Først innsendt
2. mai 2014
Først innsendt som oppfylte QC-kriteriene
8. mai 2014
Først lagt ut (Anslag)
12. mai 2014
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
19. mai 2021
Siste oppdatering sendt inn som oppfylte QC-kriteriene
28. april 2021
Sist bekreftet
1. april 2021
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- UPCC 05813
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Strålebehandling
-
West China HospitalSichuan Provincial People's Hospital; The First People's Hospital of Ziyang og andre samarbeidspartnereHar ikke rekruttert ennå
-
University Hospital HeidelbergRekruttering
-
Cancer Institute and Hospital, Chinese Academy...Sun Yat-sen UniversityUkjentLymfom, stor B-celle, diffusKina
-
Cancer Trials IrelandUniversity College Dublin; Technological University DublinRekrutteringNSCLC/Oligometastatisk kreft (enkelt lungelesjon)Irland
-
Institut für Klinische Krebsforschung IKF GmbH...AstraZeneca; Thoraxklinik-Heidelberg gGmbHRekruttering
-
Memorial Sloan Kettering Cancer CenterRekrutteringNon-Hodgkin lymfom | Non-Hodgkins lymfom, tilbakefall | Ikke-Hodgkins lymfom refraktærtForente stater
-
Ottawa Hospital Research InstituteAvsluttetBukspyttkjertelkarsinom Ikke-opererbartCanada
-
Ottawa Hospital Research InstituteUkjent
-
Poniard PharmaceuticalsAvsluttetMultippelt myelomForente stater, Canada
-
Guy's and St Thomas' NHS Foundation TrustRekrutteringHode- og nakkekreftStorbritannia